摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenoxy]oxane-2-carboxylic acid

中文名称
——
中文别名
——
英文名称
(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenoxy]oxane-2-carboxylic acid
英文别名
——
(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenoxy]oxane-2-carboxylic acid化学式
CAS
——
化学式
C21H22O12
mdl
——
分子量
466.4
InChiKey
BUONZQIZWIITTB-KIZYLBKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    207
  • 氢给体数:
    8
  • 氢受体数:
    12

文献信息

  • GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
    申请人:Kaleido Biosciences, Inc.
    公开号:EP3354282A1
    公开(公告)日:2018-08-01
    Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    本发明提供了可选择包含微量营养素、多、益生元、益生菌或其他制剂的聚糖疗法制剂、药物组合物及其医用食品,以及制造方法。还提供了使用所述糖治疗剂的方法,例如用于调节人类胃肠道微生物群和治疗菌群失调。
  • Glycan therapeutics and related methods thereof
    申请人:KALEIDO BIOSCIENCES, INC.
    公开号:US10314853B2
    公开(公告)日:2019-06-11
    Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    本发明提供了可选择包含微量营养素、多、益生元、益生菌或其他制剂的聚糖疗法制剂、药物组合物及其医用食品,以及制造方法。还提供了使用所述糖治疗剂的方法,例如用于调节人类胃肠道微生物群和治疗菌群失调。
  • Pea (Pisum sativum L.) seed coats and seed coat fractions
    申请人:The Governors of the University of Alberta
    公开号:US10342838B2
    公开(公告)日:2019-07-09
    The present disclosure embraces methodology and compositions for preparing pea seed coat fractions conferring improved health and/or other beneficial effects, and such fractions may be used in a human and/or animal diet.
    本公开包括制备豌豆种皮组分的方法和组合物,这些组分可改善健康状况和/或产生其他有益效果,并可用于人类和/或动物饮食中。
  • Pea (Pisum sativum L.) Seed Coats and Seed Coat Fractions
    申请人:The Governors of the University of Alberta
    公开号:US20160058813A1
    公开(公告)日:2016-03-03
    The present disclosure embraces methodology and compositions for preparing pea seed coat fractions conferring improved health and/or other beneficial effects, and such fractions may be used in a human and/or animal diet.
  • GLYCAN COMPOSITIONS AND USES THEREOF
    申请人:KALEIDO BIOSCIENCES, INC.
    公开号:US20180235987A1
    公开(公告)日:2018-08-23
    Compositions comprising glycan therapeutics, optionally comprising one or more oligo- or polysaccharides, probiotics, prebiotics and other agents are provided. Further, methods of generating said glycan therapeutics using polymeric catalysts are described. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of vaginal microbiota.
查看更多